Metabolon Advances Global Health Research with Gates Foundation-Backed Pilot Studies
Event summary
- Metabolon completed multiple Gates Foundation-funded pilot projects focused on women's and infant health in low- and middle-income countries.
- Studies were conducted in South Africa, Bangladesh, Pakistan, Tanzania, Zambia, Senegal, and the United States.
- Alternative sample collection methods, including dried blood spots and vaginal sampling, were evaluated for global health research.
- High-throughput mass spectrometry and advanced bioinformatics tools were used to identify metabolites associated with health outcomes.
The big picture
Metabolon's successful completion of these pilot projects addresses a significant representation gap in global health research, particularly for women and infants in low- and middle-income countries. The studies highlight the potential of metabolomics to integrate multiomic and environmental signals into clinically meaningful outcomes, benefiting underrepresented populations. This work positions Metabolon as a key partner for academic investigators, global health organizations, and biopharma teams pursuing multiomic studies in diverse populations.
What we're watching
- Biomarker Translation
- How the discovered biomarkers will be translated into diagnostic, preventive, and therapeutic interventions for vulnerable populations.
- Sample Collection Innovation
- The pace at which alternative sample collection methods will be adopted in global health research.
- Data Accessibility
- Whether the open science approach will accelerate shared discovery and collaboration in global health research.
Related topics
